Research ExplorerPublicationsAdding to the evidence or to the confusion: dual antithrombo...

Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation

Standard

Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation. / Kany, Shinwan; Schnabel, Renate.

In: HEART, Vol. 107, No. 21, 11.2021, p. 1690-1691.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Kany, S & Schnabel, R 2021, 'Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation', HEART, vol. 107, no. 21, pp. 1690-1691. https://doi.org/10.1136/heartjnl-2021-319830

APA

Kany, S., & Schnabel, R. (2021). Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation. HEART, 107(21), 1690-1691. https://doi.org/10.1136/heartjnl-2021-319830

Vancouver

Kany S, Schnabel R. Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation. HEART. 2021 Nov;107(21):1690-1691. https://doi.org/10.1136/heartjnl-2021-319830

Bibtex

@article{38669b59f3144a26aaf1f713c8cfc0f5,
title = "Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation",
keywords = "Anticoagulants/adverse effects, Atrial Fibrillation/complications, Fibrinolytic Agents/adverse effects, Humans, Platelet Aggregation Inhibitors",
author = "Shinwan Kany and Renate Schnabel",
year = "2021",
month = nov,
doi = "10.1136/heartjnl-2021-319830",
language = "English",
volume = "107",
pages = "1690--1691",
journal = "HEART",
issn = "1355-6037",
publisher = "BMJ PUBLISHING GROUP",
number = "21",

}

RIS

TY - JOUR

T1 - Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation

AU - Kany, Shinwan

AU - Schnabel, Renate

PY - 2021/11

Y1 - 2021/11

KW - Anticoagulants/adverse effects

KW - Atrial Fibrillation/complications

KW - Fibrinolytic Agents/adverse effects

KW - Humans

KW - Platelet Aggregation Inhibitors

U2 - 10.1136/heartjnl-2021-319830

DO - 10.1136/heartjnl-2021-319830

M3 - Other (editorial matter etc.)

C2 - 34385224

VL - 107

SP - 1690

EP - 1691

JO - HEART

JF - HEART

SN - 1355-6037

IS - 21

ER -